Wiebe, Sabrina

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial

Vancheri, C., Kreuter, M., Richeldi, L., Ryerson, C. J., Valeyre, D., Grutters, J. C., Wiebe, S., Stansen, W., Quaresma, M., Stowasser, S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 305

Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHD

Gruber, R., Fontil, L., Bergmame, L., Wiebe, S. T., Amsel, R., Frenette, S., & Carrier, J. (2012) · BMC Psychiatry

Sleep and related disordersAttention Deficit Hyperactivity Disorder

Cited by 77

Nocturnal sleep, daytime sleepiness, and napping among women with significant emotional/behavioral premenstrual symptoms

LAMARCHE, L. J., DRIVER, H. S., WIEBE, S., CRAWFORD, L., & DE KONINCK, J. M. (2007) · Journal of Sleep Research

Sleep and Wakefulness ResearchSleep and related disorders

Cited by 55

No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone

Richeldi, L., Fletcher, S., Adamali, H., Chaudhuri, N., Wiebe, S., Wind, S., Hohl, K., Baker, A., Schlenker-Herceg, R., Stowasser, S., et al. (2019) · European Respiratory Journal

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPharmacogenetics and Drug Metabolism

Cited by 34

Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study

Wiebe, S., Schnell, D., Külzer, R., Gansser, D., Weber, A., Wallenstein, G., Halabi, A., Conrad, A., & Wind, S. (2017) · European Journal of Drug Metabolism and Pharmacokinetics

Pharmacogenetics and Drug MetabolismLung Cancer Treatments and Mutations

Cited by 24